Scinovex
article Open AccessTop 1% cited

Hospitalizations and Deaths Caused by Methicillin-Resistant<i>Staphylococcus aureus</i>, United States, 1999–2005

Emerging infectious diseases · 2007 · Vol. 13(12) · pp. 1840–1846
Eili KleinDavid L. SmithRamanan Laxminarayan

Abstract

Hospital-acquired infections with Staphylococcus aureus, especially methicillin-resistant S. aureus (MRSA) infections, are a major cause of illness and death and impose serious economic costs on patients and hospitals. However, the recent magnitude and trend of these infections have not been reported. We used national hospitalization and resistance data to estimate the annual number of hospitalizations and deaths associated with S. aureus and MRSA from 1999 through 2005. During this period, the estimated number of S. aureus-related hospitalizations increased 62%, from 294,570 to 477,927, and the estimated number of MRSA-related hospitalizations more than doubled, from 127,036 to 278,203. Our findings suggest that S. aureus and MRSA should be considered a national priority for disease control.

Antimicrobial Resistance in StaphylococcusBacterial Identification and Susceptibility TestingAntibiotic Resistance in BacteriaStaphylococcus aureusMedicineStaphylococcal infectionsMethicillin-resistant Staphylococcus aureusIntensive care medicineEmergency medicinePediatricsBiology

MeSH terms

HospitalizationHumansStaphylococcal InfectionsStaphylococcus aureusTime FactorsUnited StatesMethicillin ResistancePneumonia, BacterialSepsis

Funding

  • Robert Wood Johnson Foundation
  • Resources for the Future
Citations
862
FWCI
25.16
field-weighted impact
References
44
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.